HOMA2-B enhances assessment of type 1 diabetes risk among TrialNet Pathway to Prevention participants.
Diabetologia
; 65(1): 88-100, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34642772
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Insulin Resistance
/
Diabetes Mellitus, Type 1
/
Diabetes Mellitus, Type 2
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Humans
Language:
En
Journal:
Diabetologia
Year:
2022
Type:
Article
Affiliation country:
United States